Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Klein Lawrence Otto
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-03-23
Sale
2021-03-25
5:39 pm
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
100,000 $128.05 $12,805,240 122,716
(Direct)
View
2021-01-15
Sale
2021-01-20
6:07 pm
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
25,000 $215.2 $5,379,940 34,666
(Direct)
View
2020-06-24
Sale
2020-06-26
4:33 pm
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
70,000 $75.88 $5,311,564 42,244
(Direct)
View
2020-05-11
Sale
2020-05-13
4:38 pm
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
25,000 $60.4 $1,509,971 58,666
(Direct)
View
2019-07-10
Sale
2019-07-12
4:13 pm
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
Chief Business Officer
20,000 $50.02 $1,000,353 155,753
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-10-12
Option Award
2022-10-13
8:07 pm
N/A
N/A
Jasper Therapeutics Inc. JSPR Klein Lawrence Otto
Director
24,500 $0 24,500
(Direct)
View
2022-08-16
Option Award
2022-08-18
5:36 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
12,500 $0 12,500
(Direct)
View
2022-07-05
Option Award
2022-07-06
6:20 pm
N/A
2030-07-30
Dyne Therapeutics Inc. DYN Klein Lawrence Otto
Director
7,222 $0 7,222
(Direct)
View
2022-06-03
Option Award
2022-06-06
4:07 pm
N/A
2032-06-02
Dyne Therapeutics Inc. DYN Klein Lawrence Otto
Director
19,596 $0 19,596
(Direct)
View
2022-03-21
Option Award
2022-03-23
6:05 pm
N/A
2032-03-21
Jasper Therapeutics Inc. JSPR Klein Lawrence Otto
Director
78,045 $0 78,045
(Direct)
View
2022-03-10
Exercise
2022-03-14
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
7,584 $0 40,380
(Direct)
View
2022-03-10
Tax Withholding
2022-03-14
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
1,883 $62.56 40,380
(Direct)
View
2022-03-10
Tax Withholding
2022-03-14
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
1,229 $61.08 40,380
(Direct)
View
2022-02-18
Option Award
2022-02-22
5:41 pm
N/A
2032-02-18
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
66,600 $0 66,600
(Direct)
View
2021-12-03
Exercise
2021-12-07
8:00 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
26,667 $0 35,658
(Direct)
View
2021-12-03
Tax Withholding
2021-12-07
8:00 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
11,185 $69.17 35,658
(Direct)
View
2021-10-15
Option Award
2021-10-18
8:00 pm
N/A
2031-10-15
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
13,800 $0 13,800
(Direct)
View
2021-09-10
Exercise
2021-09-14
9:44 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
10,000 $0 6,843
(Direct)
View
2021-09-10
Tax Withholding
2021-09-14
9:44 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
10,000 $0 6,843
(Direct)
View
2021-09-10
Tax Withholding
2021-09-14
9:44 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
4,207 $117.86 6,843
(Direct)
View
2021-05-26
Option Award
2021-05-27
8:38 pm
N/A
2031-05-25
Dyne Therapeutics Inc. DYN Klein Lawrence Otto
Director
19,596 $0 19,596
(Direct)
View
2021-03-23
Exercise
2021-03-25
5:39 pm
N/A
2027-06-14
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
88,000 $0 122,716
(Direct)
View
2021-03-23
Exercise
2021-03-25
5:39 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
22,000 $51.49 122,716
(Direct)
View
2021-03-23
Exercise
2021-03-25
5:39 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
10,000 $29.87 122,716
(Direct)
View
2021-03-23
Exercise
2021-03-25
5:39 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
20,000 $40.87 122,716
(Direct)
View
2021-03-23
Exercise
2021-03-25
5:39 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
12,000 $14.43 122,716
(Direct)
View
2021-03-23
Exercise
2021-03-25
5:39 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
12,000 $17.66 122,716
(Direct)
View
2021-03-23
Exercise
2021-03-25
5:39 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
12,000 $44.67 122,716
(Direct)
View
2021-03-10
Exercise
2021-03-12
5:47 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
4,583 $0 58,384
(Direct)
View
2021-03-10
Option Award
2021-03-12
5:47 pm
N/A
2031-03-11
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
45,334 $0 58,384
(Direct)
View
2021-03-10
Tax Withholding
2021-03-12
5:47 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
2,141 $124.15 58,384
(Direct)
View
2021-01-15(A)
Exercise
2021-03-12
5:37 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
16,334 $14.43 37,550
(Direct)
View
2021-01-15
Exercise
2021-01-20
6:07 pm
N/A
2026-07-14
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
25,000 $0 34,666
(Direct)
View
2021-01-15
Exercise
2021-01-20
6:07 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
8,666 $12.57 34,666
(Direct)
View
2021-01-15
Exercise
2021-01-20
6:07 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
16,344 $14.43 34,666
(Direct)
View
2021-01-02
Tax Withholding
2021-01-04
4:12 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
9,392 $153.11 10,608
(Direct)
View
2020-10-05
Option Award
2020-10-06
5:38 pm
N/A
2030-10-05
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
16,666 $0 16,666
(Direct)
View
2020-07-31
Option Award
2020-09-23
7:04 pm
N/A
2030-07-30
Dyne Therapeutics Inc. DYN Klein Lawrence Otto
Director
25,600 $0 71,899
(Direct)
View
2020-07-31
Conversion
2020-09-23
7:04 pm
N/A
N/A
Dyne Therapeutics Inc. DYN Klein Lawrence Otto
Director
46,299 $0 71,899
(Direct)
View
2020-09-16
Ownership
2020-09-16
8:43 pm
N/A
2029-09-05
Dyne Therapeutics Inc. DYN Klein Lawrence Otto
Director
0 $0 69,133
(Direct)
View
2020-06-24
Exercise
2020-06-26
4:33 pm
N/A
2026-03-01
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
70,000 $0 42,244
(Direct)
View
2020-06-24
Exercise
2020-06-26
4:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
31,334 $12.57 42,244
(Direct)
View
2020-06-24
Exercise
2020-06-26
4:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
38,666 $5.86 42,244
(Direct)
View
2020-05-11
Exercise
2020-05-13
4:38 pm
N/A
2026-03-01
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
25,000 $0 58,666
(Direct)
View
2020-05-11
Exercise
2020-05-13
4:38 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
25,000 $5.86 58,666
(Direct)
View
2020-03-10
Option Award
2020-03-12
4:10 pm
N/A
2030-03-10
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
COO
68,750 $0 68,750
(Direct)
View
2019-12-03
Option Award
2019-12-05
4:05 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
Chief Business Officer
40,000 $0 40,000
(Direct)
View
2019-09-10
Option Award
2019-09-12
4:32 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
Chief Business Officer
10,000 $0 30,000
(Direct)
View
2019-07-10
Exercise
2019-07-12
4:13 pm
N/A
2026-03-01
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
Chief Business Officer
20,000 $0 155,753
(Direct)
View
2019-07-10
Exercise
2019-07-12
4:13 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
Chief Business Officer
20,000 $5.86 155,753
(Direct)
View
2019-03-05
Option Award
2019-03-07
4:17 pm
N/A
2029-03-05
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
Chief Business Officer
45,000 $0 45,000
(Direct)
View
2019-01-02
Option Award
2019-01-03
4:32 pm
N/A
2029-01-01
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
Chief Business Officer
20,000 $0 40,000
(Direct)
View
2019-01-02
Option Award
2019-01-03
4:32 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
Chief Business Officer
20,000 $29.87 40,000
(Direct)
View
2019-01-02
Ownership
2019-01-03
4:22 pm
N/A
2026-03-01
CRISPR Therapeutics AG CRSP Klein Lawrence Otto
Chief Business Officer
0 $0 229,666
(Direct)
View
(A) Indicate amendment filing.